Novel AKI biomarkers such as kidney injury molecule 1 (KIM-1), neutrophil gelatinase associated lipocalin (NGAL), IL-18, and Cystatin C can diagnose AKI prior to detectable changes in sCr [11-19]. Here, CST3 is linked to acute kidney injury.